Magrolimab (CD47) - Research Grade Biosimilar
Product Specifications
Background
Magrolimab is anti-CD47 monoclonal antibody designed to promote phagocytosis of cancer cells by macrophages. Its purpose is to interfere with the recognition of CD47 by SIRPα receptors on macrophages, thereby blocking the self-protection signals used by cancer cells to avoid being swallowed by macrophages.
Immunogen
Chimeric, Humanized / CD47 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG4-kappa
NCBI Organism
Homo sapiens
Other Product Names
Hu5F9-G4
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
041616-ML490 100 µL
SF3B4, ID (SF3B4, SAP49, Splicing factor 3B subunit 4, Pre-mRNA-splicing factor SF3b 49kD subunit, SF3b50, Spliceosome-associated protein 49) (MaxLight 490) discontinued
Sign In for Pricing
View Details LV687955 1.0 µg DNA
Il4ra Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
